Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Primary mediastinal large B-cell lymphoma differential diagnosis

Introduction

Overview

Overview

Primary mediastinal large B-cell lymphoma must be differentiated from other diseases that cause swollen face, superior vena cava syndrome, and fever, night sweats and weight loss such as hodgkin’s lymphoma, thymoma, and other non hodgkin’s lymphomas.

Differentiating [Disease name] from other Diseases

Differentiating [Disease name] from other Diseases

  • The differentiation is determined on the basis of biopsy findings and immunophenotype, which are as follows:
References

References

  1. ↑ Kodama T, Watanabe S, Sato Y, Shimosato Y, Miyazawa N (January 1986). “An immunohistochemical study of thymic epithelial tumors. I. Epithelial component”. Am. J. Surg. Pathol. 10 (1): 26–33. PMIDΒ 2420219.
  2. ↑ von Wasielewski R, Mengel M, Fischer R, Hansmann ML, HΓΌbner K, Franklin J, Tesch H, Paulus U, Werner M, Diehl V, Georgii A (October 1997). “Classical Hodgkin’s disease. Clinical impact of the immunophenotype”. Am. J. Pathol. 151 (4): 1123–30. PMCΒ 1858022. PMIDΒ 9327746.
  3. ↑ Suster S, Rosai J (February 1991). “Thymic carcinoma. A clinicopathologic study of 60 cases”. Cancer. 67 (4): 1025–32. PMIDΒ 1991250.
  4. ↑ Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (May 2016). “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia”. Blood. 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMIDΒ 27069254.
  5. ↑ Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A (November 2000). “The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity”. J. Clin. Oncol. 18 (22): 3809–18. doi:10.1200/JCO.2000.18.22.3809. PMIDΒ 11078494.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2]